Soligenix Inc
Change company Symbol lookup
Select an option...
SNGX Soligenix Inc
ABCB Ameris Bancorp
YRIV Yangtze River Port and Logistics Ltd
PINVF Pinnacle Investment Management Group Ltd
PNFPP Pinnacle Financial Partners Inc
KGHZF Pangolin Diamonds Corp
PUCCF Pancontinental Resources Corporation
PCOGF Pancontinental Oil & Gas NL
PXLIF Panaxia Labs Israel Ltd
CHPEF China PengFei Group Ltd
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Soligenix, Inc. (Soligenix) is a late-stage biopharmaceutical company. The Company is focused on developing and commercializing products to treat rare diseases. The Company operates through two business segments: Specialized BioTherapeutics and Public Health Solution. Soligenix’s Specialized BioTherapeutics business segment is developing a photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of cutaneous T-cell lymphoma (CTCL). The Public Health Solutions business segment includes active development programs for RiVax, its ricin toxin vaccine candidate and SGX943, its therapeutic candidate for antibiotic-resistant and emerging infectious disease. CTCL is its innate defense regulator technology, dusquetide (SGX942) for the treatment of oral mucositis in head and neck cancer.

Closing Price
$0.9646
Day's Change
-0.0194 (-1.97%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.988
Day's Low
0.9425
Volume
(Below Average)
Volume:
257,052

10-day average volume:
306,318
257,052

Display:

Providers:

UpdateCancel
6 providers
July 22, 2021
July 08, 2021
July 06, 2021
June 23, 2021
June 22, 2021
June 17, 2021
June 10, 2021
June 09, 2021
May 20, 2021
May 17, 2021
May 10, 2021
May 04, 2021
April 28, 2021

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.